中华眼科医学杂志（电子版）
中華眼科醫學雜誌（電子版）
중화안과의학잡지（전자판）
CHINESE JOURNAL OF OPHTHALMOLOGIC MEDICINE(ELECTRONIC EDITION)
2013年
2期
92-94
,共3页
鼻腔内窥镜%泪道阻塞%泪道支架
鼻腔內窺鏡%淚道阻塞%淚道支架
비강내규경%루도조새%루도지가
Nasal endoscope%Nasolacrimal duct obstruction%Lacrimal passages stent
目的：观察鼻腔内窥镜下泪道支架植入术治疗泪道阻塞的临床疗效。方法回顾性分析山东省滨州市中心医院眼科2010年2月至2011年12月期间采用Fr7、Fr8和Fr9型泪道支架治疗19例（20只眼）泪道阻塞患者的临床资料，在患者泪道和鼻腔黏膜表面麻醉下经鼻腔逆行插入泪道支架，治疗泪道阻塞。术前对患者进行泪道造影和泪道冲洗，并确定泪道阻塞的部位，检查确定泪囊的大小，CT检查鼻泪管以确定鼻泪管的骨道粗细。术后1周每日冲洗泪道1次，之后每月冲洗泪道1次。归纳鼻腔内窥镜下泪道支架植入术治疗泪道阻塞的临床疗效。结果本组19例（20只眼）患者，术中均成功植入泪道支架，2只眼于术后3～5 d 发生支架阻塞，经及时冲洗后泪道恢复通畅。术后对患者进行1～13个月的随访，平均10个月，溢泪症状消失、冲洗泪道通畅者19只眼（95％）。溢泪、冲洗欠通畅者1只眼（5％）。结论泪道支架植入术是一种新型治疗泪道阻塞的治疗方法，具有简便、安全和有效的优点。
目的：觀察鼻腔內窺鏡下淚道支架植入術治療淚道阻塞的臨床療效。方法迴顧性分析山東省濱州市中心醫院眼科2010年2月至2011年12月期間採用Fr7、Fr8和Fr9型淚道支架治療19例（20隻眼）淚道阻塞患者的臨床資料，在患者淚道和鼻腔黏膜錶麵痳醉下經鼻腔逆行插入淚道支架，治療淚道阻塞。術前對患者進行淚道造影和淚道遲洗，併確定淚道阻塞的部位，檢查確定淚囊的大小，CT檢查鼻淚管以確定鼻淚管的骨道粗細。術後1週每日遲洗淚道1次，之後每月遲洗淚道1次。歸納鼻腔內窺鏡下淚道支架植入術治療淚道阻塞的臨床療效。結果本組19例（20隻眼）患者，術中均成功植入淚道支架，2隻眼于術後3～5 d 髮生支架阻塞，經及時遲洗後淚道恢複通暢。術後對患者進行1～13箇月的隨訪，平均10箇月，溢淚癥狀消失、遲洗淚道通暢者19隻眼（95％）。溢淚、遲洗欠通暢者1隻眼（5％）。結論淚道支架植入術是一種新型治療淚道阻塞的治療方法，具有簡便、安全和有效的優點。
목적：관찰비강내규경하루도지가식입술치료루도조새적림상료효。방법회고성분석산동성빈주시중심의원안과2010년2월지2011년12월기간채용Fr7、Fr8화Fr9형루도지가치료19례（20지안）루도조새환자적림상자료，재환자루도화비강점막표면마취하경비강역행삽입루도지가，치료루도조새。술전대환자진행루도조영화루도충세，병학정루도조새적부위，검사학정루낭적대소，CT검사비루관이학정비루관적골도조세。술후1주매일충세루도1차，지후매월충세루도1차。귀납비강내규경하루도지가식입술치료루도조새적림상료효。결과본조19례（20지안）환자，술중균성공식입루도지가，2지안우술후3～5 d 발생지가조새，경급시충세후루도회복통창。술후대환자진행1～13개월적수방，평균10개월，일루증상소실、충세루도통창자19지안（95％）。일루、충세흠통창자1지안（5％）。결론루도지가식입술시일충신형치료루도조새적치료방법，구유간편、안전화유효적우점。
Objective To observe the clinical efficacy of lacrimal duct stent for nasolacrimal duct obstruction under nasal endoscope.Methods It was a retrospective study.Nineteen patients (20 eyes) of lacrimal duct obstruction using Fr 7,Fr 8 or Fr 9 type lacrimal stent produced by Shandong Furuida biological chemical co.Ltd since Feb.2010 in department of ophthalmology,Binzhou Cental Hospital were included in this study.Before the surgery,lacrimal duct imaging and lacrimal passage irrigation were taken to confirm the site of obstruction and the size of the lacrimal sac.CT scan was made to check the caliber of nasolacrimal canal bone road.Under topical anesthesia of lacrimal passages and nose mucous membrane,Fr 7,Fr 8 or Fr 9 type lacrimal stent was retrogradely inserted into nasal cavity.The lacrimal passages was irrigated once a day during the first week after operation,then once a month.There were 1-13 months followed-up was made and the clinical efficacy of lacrimal duct stent was observed.Results Lacrimal duct stents were successfully implanted in all 19 patients (20 eyes) .Stent blocking occurred in 2 eyes 3-5 days postsurgery and got clear after lacrimal passage irrigation.Ten months after surgery,19 eyes (95%) had unobstructed lacrimal duct, epiphora was observed in only 1 eye (5%).Conclusion Lacrimal passages stenting under nasal endoscope is a new,simple,safe and effective method in treating nasolacrimal duct obstruction.
